Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Saronic files IND for phase I/II trial of SBI-1997 for hepatocellular carcinoma

Dec. 22, 2015

FDA approves Keytruda for first-line treatment of unresectable or metastatic melanoma

Dec. 21, 2015

Cells transduced with the inducible caspase-9 suicide gene well tolerated in children

Dec. 21, 2015

First clinical trial results for nivolumab in ovarian cancer

Dec. 21, 2015

Imlygic approved in E.U. for unresectable melanoma that is distantly or regionally metastatic

Dec. 18, 2015

FDA lifts clinical hold on Advaxis cancer vaccines

Dec. 17, 2015

Probody drug conjugate targeting CD166 shows promise for the treatment of cancer

Dec. 17, 2015

Idera Pharmaceuticals begins phase I/II trial of intratumoral IMO-2125

Dec. 17, 2015

Committee backs E.U. orphan drug designation for axalimogene filolisbac in anal cancer

Dec. 16, 2015

EMA supports E.U. orphan drug designation for Aduro Biotech's CRS-207 and GVAX pancreas

Dec. 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...